StockNews.com Downgrades H.B. Fuller (NYSE:FUL) to Hold

H.B. Fuller (NYSE:FUL) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Monday.

H.B. Fuller Stock Down 0.2 %

NYSE FUL traded down $0.18 on Monday, hitting $79.25. The stock had a trading volume of 256,694 shares, compared to its average volume of 301,327. The business’s fifty day moving average price is $81.46 and its 200 day moving average price is $79.42. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.89 and a quick ratio of 1.16. H.B. Fuller has a 52-week low of $64.64 and a 52-week high of $87.67. The stock has a market cap of $4.32 billion, a price-to-earnings ratio of 27.05, a price-to-earnings-growth ratio of 1.29 and a beta of 1.42.

H.B. Fuller (NYSE:FUL) last posted its quarterly earnings data on Thursday, June 27th. The specialty chemicals company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.03 by $0.09. The business had revenue of $917.10 million during the quarter, compared to the consensus estimate of $914.22 million. H.B. Fuller had a net margin of 4.67% and a return on equity of 13.33%. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.93 earnings per share. Equities research analysts anticipate that H.B. Fuller will post 4.4 earnings per share for the current year.

Insider Buying and Selling at H.B. Fuller

In other H.B. Fuller news, VP Heather Campe sold 23,696 shares of H.B. Fuller stock in a transaction on Friday, July 12th. The shares were sold at an average price of $82.66, for a total value of $1,958,711.36. Following the completion of the transaction, the vice president now owns 19,742 shares of the company’s stock, valued at $1,631,873.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.96% of the stock is owned by corporate insiders.

Institutional Trading of H.B. Fuller

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Marshall Wace LLP increased its stake in shares of H.B. Fuller by 9.9% during the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock worth $22,319,000 after purchasing an additional 26,239 shares in the last quarter. Dorsey & Whitney Trust CO LLC boosted its holdings in H.B. Fuller by 8.1% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 71,354 shares of the specialty chemicals company’s stock valued at $5,491,000 after purchasing an additional 5,356 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in H.B. Fuller by 1.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 525,731 shares of the specialty chemicals company’s stock valued at $40,460,000 after purchasing an additional 7,292 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in H.B. Fuller by 3.1% in the 2nd quarter. New York State Teachers Retirement System now owns 88,348 shares of the specialty chemicals company’s stock valued at $6,799,000 after purchasing an additional 2,694 shares during the last quarter. Finally, Central Pacific Bank Trust Division acquired a new position in H.B. Fuller in the 1st quarter valued at about $79,000. Hedge funds and other institutional investors own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.